Imexpharm Corp (IMP) — Capital Reinvestment Ratio
Imexpharm Corp (IMP) has a Capital Reinvestment Ratio of 0.30x as of June 2026, meaning it reinvests 0% of its operating cash flow (₫55.75 Billion) in capital expenditures (₫16.90 Billion). Check Imexpharm Corp tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Imexpharm Corp Capital Reinvestment Ratio (2019–2025)
This chart tracks Imexpharm Corp's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see IMP operating cash flow.
Annual Capital Reinvestment Ratio for Imexpharm Corp (2019–2025)
Year-by-year Capital Reinvestment Ratio for Imexpharm Corp from 2019 to 2025. See IMP FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.50x | ₫54.17 Billion | ₫26.88 Billion | ▲ +10.9% |
| 2024 | 0.45x | ₫216.27 Billion | ₫96.77 Billion | ▲ +70.5% |
| 2022 | 0.26x | ₫378.60 Billion | ₫99.35 Billion | ▲ +16.6% |
| 2021 | 0.23x | ₫234.88 Billion | ₫52.86 Billion | ▼ -81.6% |
| 2020 | 1.23x | ₫73.15 Billion | ₫89.68 Billion | ▼ -37.7% |
| 2019 | 1.97x | ₫66.59 Billion | ₫131.12 Billion | — |